Grade: Pharmaceutical Grade

Factory Location: Xiamen

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Monthly Production Capacity: 10tons/year

Contract Manufacturing: CRO,CMO

Packaging Information: 25kg/bag

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/C

Product name	Levetiracetam
CAS No.	102767-28-2
Molecular Formula	C4H11NO
Molecular Weight	170.211
Quality Standard	98% up by HPLC
Appearance	White or almost white powder

 

 

COA

 

 

 

ANALYSIS	SPECIFICATION	RESULTS
Appearance	White or almost white powder	White powder
Assay	98.0% - 102.0%	99.2%
Water	≤ 0.5%	≤ 0.1%
Residue on ignition	≤ 0.1%	≤ 0.1%
Heavy metals	≤ 20ppm	< 20ppm
Enantiomeric purity	≤ 0.8%	Not detected
Conclusion	The sample complies with the USP standard.

 

 

Usage

 

Levetiracetam is a medication primarily used to treat certain types of seizures in patients with epilepsy. It is a white crystalline powder with a specific chemical structure, namely (S)-α-ethyl-2-oxo-1-pyrrolidine acetamide, and has a molecular formula of C8H14N2O2.

Levetiracetam functions primarily as an anticonvulsant drug, which means it is designed to prevent or reduce the frequency and severity of seizures in patients with epilepsy. The exact mechanism of action of Levetiracetam is believed to work by binding to a protein called synaptic vesicle protein 2A (SV2A) located in the presynaptic terminal of neurons. This binding is thought to interfere with the release of neurotransmitters, specifically glutamate, which is involved in the generation and spread of seizures. By modulating glutamate release, Levetiracetam can reduce the likelihood of seizures occurring.